Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Jul 13, 2011

Premium

Former Myriad Genetic Laboratories President Gregory Critchfield has joined the board of directors at Saladax Biomedical. Before working at Myriad, which he left in 2010, Critchfield was CMO and CSO at Corning Clinical Laboratories, and he was a medical school faculty member at the University of Minnesota, Wayne State University, and Duke University. Critchfield also has served as a director at Metamark Genetics, Biocius Life Sciences, and BioTrove.


23andMe has appointed Ashley Dombkowski to be its chief business officer, where she will be responsible for the firm's translational collaboration initiatives. Dombkowski, who has previously been a member of the company's board of directors, spent 10 years at MPM Capital as managing director and also formerly was a healthcare analyst at Tiger Management and Dresdner RCM Global Investors.

Filed under

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.